A chair may make yoga more accessible, but does the practice still offer meaningful physical and mental experiences? A qualitative evaluation of the Gentle Years Yoga trial, led by Lesley Ward and colleagues from Northumbria University, York St John University, the University of York, and British Wheel of Yoga Qualifications, explored what older adults themselves said after participating in a 12-week chair-based yoga program.
Yoga does not always require getting down on a mat. The Gentle Years Yoga (GYY) trial investigated a functionally inclusive chair-based approach for adults aged 65 and older living with multiple long-term health conditions.
The 12-week program included weekly 75-minute group classes together with home-practice guidance. Rather than focusing solely on physical movement, the program incorporated physical practices, breathing, and relaxation. Interviews with 25 participants revealed a striking range of experiences from little perceived benefit to changes participants described as transformative. Reported physical experiences included improvements in muscle strength, posture awareness, mobility, balance, coordination, upper-body range of motion, pain, and stiffness. Participants particularly associated gentle joint mobilisation and range-of-motion movements with these changes.
But movement was only part of the story. Many participants considered breathing and relaxation to be what made yoga different from conventional exercise. Breath awareness was associated with calm, mental focus, emotional well-being, and improved sleep, and some participants incorporated these techniques into everyday situations. Perhaps most importantly, participants learned to adapt yoga to their individual needs using movement for stiffness, breathing for stressful moments, or relaxation when needed. For some, yoga evolved from a weekly class into a personalized health-management toolkit.
The study also provides an important reality check: not everyone experienced meaningful benefits, and the separately reported randomized trial found no significant overall advantage over usual care on its primary and secondary quantitative outcomes.
